For citations:

Murashko R.A., Sharov S.V., Chashnikova E.P. Trastuzumab deruxtecan for the late lines of treatment for HER2-low metastatic breast cancer: a clinical case. Tumors of female reproductive system. 2024;20(4):95-100. (In Russ.) https://doi.org/10.17650/1994-4098-2024-20-4-95-100